- Phase 3 topline data from azetukalner FOS epilepsy program planned for H2 2025 in support of NDA filing and potential commercial launch - First of three planned Phase 3 azetukalner MDD studies ...
Dr. Waltzman’s panel, titled “Ensuring Effective and Efficient Trials Through Clinical Operations” will be Monday, April 7 th from 4:05PM – 4:35PM ET.
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nevro Corp (NVRO – Research Report), Globus ...
Stäubli Robotics in collaboration with a prominent pharmaceutical company has developed a mobile robot for use in Grade A/B/C/D cleanrooms. A cross-functional team ...
PhaseV, a leader in AI/ML-driven clinical development, announced today that it will demonstrate new capabilities of its platform for clinical trials at the upcoming Chief Medical Officer (CMO) Summit ...
Revenue of $3.3 Million, a 12% Increase Compared to Prior Year ~ ~ Interim Analysis from MAINSAIL Study Reinforces Safety ...
Pharmaceutical Refrigerator MED-125 from Kirsch Pharmaceutical Refrigerator MED-85 from Kirsch High Credibility: This website adheres to all nine standards of credibility and transparency.
The Global Medical Tapes and Bandages Market is projected to grow at a CAGR of 6.0% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that the ...
Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. Most of the major U.S. pharmaceutical companies (AbbVie, Amgen, Bristol Myers ...
DelveInsight recently conducted an in-depth MASH Market Size and Share Assessment to help a pharmaceutical client understand the evolving Metabolic Dysfunction-Associated Steatohepatitis (MASH) market ...
Mar. 18, 2025 — A research team has found that lecanemab was probably less effective in females than males in its Phase 3 trial. However, there was insufficient evidence to say the drug was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results